Information Library
Results for: Cost control/reduction - Demonstrating Value
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
A Blueprint for Clinical / Commercial Convergence
White Paper — August 5, 2010
The development model for bio pharmaceutical companies must shift from two divergent paths to one that combines these two resources with market access strategy, information and capabilities. -
Podcast: A New Gold Standard
Hear from the Experts — May 1, 2008
John Doyle discusses the concept of a health economic balance sheet and the need for evidence-based pricing for biopharmaceutical valuation.
Page 1 of 1 (2 results)
